Volitionrx (VNRX) Share-based Compensation Growth (5y) (2016 - 2025)
Volitionrx (VNRX) Share-based Compensation Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 173.90 Bn | 6.27 Bn |
| 2 | Stryker | 128.53 Bn | 125.65 Bn | 3.81 Bn |
| 3 | Medtronic | 107.77 Bn | 98.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.72 Bn | 66.27 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.21 Bn | 44.54 Bn | 1.29 Bn |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.05 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.76 Bn | 26.18 Bn | - |
| 9 | Koninklijke Philips | 25.27 Bn | 22.15 Bn | 2.07 Bn |
| 10 | Volitionrx | 99,574.04 | -1.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 31.87% |
| Jun 30, 2025 | -24.23% |
| Mar 31, 2025 | 22.23% |
| Dec 31, 2024 | -43.67% |
| Sep 30, 2024 | 58.86% |
| Jun 30, 2024 | 56.88% |
| Mar 31, 2024 | 7.56% |
| Dec 31, 2023 | -29.19% |
| Sep 30, 2023 | -3.65% |
| Jun 30, 2023 | 3.73% |
| Mar 31, 2023 | -4.97% |
| Dec 31, 2022 | 37.30% |
| Sep 30, 2022 | -11.25% |
| Jun 30, 2022 | -13.35% |
| Mar 31, 2022 | 9.39% |
| Dec 31, 2021 | -13.52% |
| Sep 30, 2021 | 7.83% |
| Jun 30, 2021 | -4.57% |
| Mar 31, 2021 | 29.47% |
| Dec 31, 2020 | -28.83% |